Radical surgery for mesothelioma

British Medical Journal

Volumn 328, Issue 7434, 2004, Pages 237-238

  Treasure, Tom ^a   Waller, David ^b   Swift, Simon ^a   Peto, Julian ^c  

^a GUY S HOSPITAL   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

CLINICAL FEATURE; CYTODIAGNOSIS; DIAGNOSTIC PROCEDURE; EDITORIAL; ENVIRONMENTAL EXPOSURE; EPIDEMIC; HUMAN; LUNG RESECTION; MESOTHELIOMA; MORBIDITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; UNITED KINGDOM;

EID: 0842330312     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7434.237     Document Type: Editorial

References (12)

1. White C. Annual deaths from mesothelioma in Britain to reach 2000 by 2010. BMJ 2003;326:1417.
2. Johnson R, McIvor A. Lethal work: a history of the asbestos tragedy in Scotland. East Linton: Tuckwell, 2000.
3. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 1995;345:535-9.
4. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72.
5. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997;145:211-8.
6. British Thoracic Society. BTS statement on malignant mesothelioma in the United Kingdom, 2001. Thorax 2001;56:250-65.
7. Tan C, Swift S, Gilham C, Shaefi S, Fountain SW, Peto J, et al. Survival in surgically diagnosed patients with malignant mesothelioma in current practice. Thorax 2002;57iii:iii36.
8. Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O'Byrne KJ. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 2000;55:731-5.
9. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15-24.
10. Butchart EG. Contemporary management of malignant pleural mesothelioma. Oncologist 1999;4:488-500.
11. Treasure T, Swift S, Tan C. Radical surgery for mesothelioma: how can we obtain evidence? World J Surg 2003;27:891-4.
12. Girling DJ, Muers MF, Qian W, Lobban D. Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council. Semin Oncol 2002;29:97-101.